Penn Medicine 2020 Updates in Oncology
2020 ASCO GI Cancer Update: Are CPIs Superior to 2nd Line Chemo in SSC of Esophagus? Is CROSS Regimen Beneficial in Neoadjuvant HER2+ Esophageal Adenocarcinoma? Are CPIs More Beneficial Than Paclitaxel in Gastric Adenocarcinoma?
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Jennifer Eads
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Jennifer Eads
Login to view comments.
Click here to Login